logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.

date
18:35 24/09/2024
avatar
GMT Eight
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
HK Stock
Chairman Wang Linbing increased his holdings of 14.86 million shares in S Harbourhold (stock code: 01663).
Chairman Guo Jianxin reduced his holdings of CN ANCHU ENERGY (02399) by 490,000 shares at a price of HKD 0.79 per share.
JPMorgan Chase increases its stake in ALI HEALTH (00241) by approximately 172 million shares at a price of HK$6.069 per share.
Chairman Wang Linbing increased his holdings of 14.86 million shares in S Harbourhold (stock code: 01663).
HK Stock
Chairman Guo Jianxin reduced his holdings of CN ANCHU ENERGY (02399) by 490,000 shares at a price of HKD 0.79 per share.
JPMorgan Chase increases its stake in ALI HEALTH (00241) by approximately 172 million shares at a price of HK$6.069 per share.
RECOMMEND
In 2025, Investors No Longer Favor Beauty Brands
In 2025, Investors No Longer Favor Beauty Brands
icon
02/12/2025
Foreign Investment Giants Raise Forecasts, China Stocks “Overweight,” Technology And Consumption As Key Focus
Foreign Investment Giants Raise Forecasts, China Stocks “Overweight,” Technology And Consumption As Key Focus
icon
02/12/2025
Listing, “Encirclement,” And RMB 2.89 Billion Delivery Fees: Luckin Coffee Has No Way Back In 2025
Listing, “Encirclement,” And RMB 2.89 Billion Delivery Fees: Luckin Coffee Has No Way Back In 2025
icon
02/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.